Search research articles
Contact Us
Filters
Showing results (121-130 of 132) with videos related to
Page
of 14
Sort By:
Oncogene
|
April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
S Boehrer, L Adès, N Tajeddine, et al.
Annals of Hematology
|
November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia
W K Hofmann, G Seipelt, S Langenhan, et al.
Leukemia
|
November 5, 2013
Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients
U Platzbecker, H K Al-Ali, N Gattermann, et al.
Leukemia
|
July 6, 2012
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study
F J Giles, P D le Coutre, J Pinilla-Ibarz, et al.
Leukemia
|
November 24, 2012
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance
E Jabbour, P D le Coutre, J Cortes, et al.
Leukemia
|
May 27, 2017
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts
G Garcia-Manero, M A Sekeres, M Egyed, et al.
Leukemia
|
December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia
H Pfeifer, B Wassmann, W Bethge, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
Leukemia
|
March 27, 2004
The German competence network 'Acute and chronic leukemias'
R Hehlmann, U Berger, C Aul, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 132) with videos related to
Sort By:
Page
of 14
Oncogene
|
April 29, 2009
Suppression of the DNA damage response in acute myeloid leukemia versus myelodysplastic syndrome
S Boehrer, L Adès, N Tajeddine, et al.
Annals of Hematology
|
November 9, 2002
Prospective randomized trial to evaluate two delayed granulocyte colony stimulating factor administration schedules after high-dose cytarabine therapy in adult patients with acute lymphoblastic leukemia
W K Hofmann, G Seipelt, S Langenhan, et al.
Leukemia
|
November 5, 2013
Phase 2 study of oral panobinostat (LBH589) with or without erythropoietin in heavily transfusion-dependent IPSS low or int-1 MDS patients
U Platzbecker, H K Al-Ali, N Gattermann, et al.
Leukemia
|
July 6, 2012
Nilotinib in imatinib-resistant or imatinib-intolerant patients with chronic myeloid leukemia in chronic phase: 48-month follow-up results of a phase II study
F J Giles, P D le Coutre, J Pinilla-Ibarz, et al.
Leukemia
|
November 24, 2012
Prediction of outcomes in patients with Ph+ chronic myeloid leukemia in chronic phase treated with nilotinib after imatinib resistance/intolerance
E Jabbour, P D le Coutre, J Cortes, et al.
Leukemia
|
May 27, 2017
A phase 1b/2b multicenter study of oral panobinostat plus azacitidine in adults with MDS, CMML or AML with ⩽30% blasts
G Garcia-Manero, M A Sekeres, M Egyed, et al.
Leukemia
|
December 6, 2012
Randomized comparison of prophylactic and minimal residual disease-triggered imatinib after allogeneic stem cell transplantation for BCR-ABL1-positive acute lymphoblastic leukemia
H Pfeifer, B Wassmann, W Bethge, et al.
Leukemia
|
October 3, 2003
Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C
M C Müller, N Gattermann, T Lahaye, et al.
Leukemia
|
December 25, 2009
Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008
M Brüggemann, A Schrauder, T Raff, et al.
Leukemia
|
March 27, 2004
The German competence network 'Acute and chronic leukemias'
R Hehlmann, U Berger, C Aul, et al.
Page
of 14